UNSPSC 51263105: Bisoprolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H31NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y41JS2NL6U, chemically known as 2-propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)- but generally known as bisoprolol, which bears US NIH Compound Identifier 2405. Bisoprolol most often comes in base and fumarate forms.

UNSPSC 51263105 Bisoprolol, a Commodity code, does not align with recent state and local procurement activity in the available source data. The single recent opportunity associated with this code—Seminole County, Florida's IFB60459723LAS—solicits naloxone and safe drug deactivation systems for community health initiatives, which falls outside the pharmaceutical beta-blocker scope that the code nominally describes. The mismatch suggests either a classification error in the county's tagging or a narrow, specialized use case that does not represent the broader activity under this code.

Without representative opportunities actually purchasing bisoprolol or similar beta-blockers through state and local channels, the source provides no reliable basis for characterizing issuing-body mix, geographic spread, or current market demand under this code. Business development professionals should verify whether state and local health departments, pharmacy benefit managers, or correctional facilities are actively procuring bisoprolol through open bidding before investing pursuit resources. If the code does carry relevant activity, it likely routes through state health or human services departments rather than county-level health authorities, but the available data does not confirm this.